Analytical Data
-
Gene name
CASD1
- Application
-
Alternative Names
CASD1; C7orf12; Nbla04196N-acetylneuraminate 9-O-acetyltransferase; EC 2.3.1.45; CAS1 domain-containing protein 1; Sialate O-acetyltransferase; SOAT
-
Species
Human
-
Source
E. coli
-
Tag
N- His-SUMO
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q96PB1
-
Expression Region
39-313aa
-
Molecular Weight
47.2 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CASD1 (Cancer Associated SD1) is a protein that has garnered attention in cancer research due to its potential role in tumor progression and metastasis. Emerging studies suggest that CASD1 may be involved in important cellular processes such as cell proliferation, apoptosis, and the regulation of metabolic pathways. Its expression levels have been correlated with various cancer types, indicating its utility as a potential biomarker for cancer diagnosis and prognosis. The recombinant production of CASD1 enables researchers to investigate its structural properties, functional mechanisms, and interactions with other biomolecules in detail. By generating high-purity recombinant CASD1, scientists can conduct in vitro and in vivo studies to elucidate its role in cancer biology. Understanding the molecular functions and pathways influenced by CASD1 may provide insights into novel therapeutic strategies or interventions. Furthermore, as research continues to explore the relationship between CASD1 and various oncogenic pathways, it holds promise for contributing to the development of targeted therapies aimed at improving patient outcomes in cancer treatment.
